✓ No loaded language, vague sourcing, or framing detected.
The DEA plans to temporarily classify the synthetic kratom compound 7-hydroxymitragynine (7-OH) and three related substances as Schedule I drugs. This classification indicates that these substances have no accepted medical use and a high potential for abuse.
Our neutral summary
The DEA plans to temporarily classify the synthetic kratom compound 7-hydroxymitragynine (7-OH) and three related substances as Schedule I drugs. This classification indicates that these substances have no accepted medical use and a high potential for abuse.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
DEA moves to ban opioid-like kratom compound 7-OH
DEA Proposes Temporary Ban on Synthetic Kratom Compound 7-OH